TITLE

Outcomes among HIV-1 Infected Individuals First Starting Antiretroviral Therapy with Concurrent Active TB or Other AIDS-Defining Disease

AUTHOR(S)
Périssé, André R. S.; Smeaton, Laura; Chen, Yun; La Rosa, Alberto; Walawander, Ann; Nair, Apsara; Grinsztejn, Beatriz; Santos, Breno; Kanyama, Cecilia; Hakim, James; Nyirenda, Mulinda; Kumarasamy, Nagalingeswaran; Lalloo, Umesh G.; Flanigan, Timothy; Campbell, Thomas B.; Hughes, Michael D.
PUB. DATE
December 2013
SOURCE
PLoS ONE;Dec2013, Vol. 8 Issue 12, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Tuberculosis (TB) is common among HIV-infected individuals in many resource-limited countries and has been associated with poor survival. We evaluated morbidity and mortality among individuals first starting antiretroviral therapy (ART) with concurrent active TB or other AIDS-defining disease using data from the “Prospective Evaluation of Antiretrovirals in Resource-Limited Settings” (PEARLS) study. Methods: Participants were categorized retrospectively into three groups according to presence of active confirmed or presumptive disease at ART initiation: those with pulmonary and/or extrapulmonary TB (“TB” group), those with other non-TB AIDS-defining disease (“other disease”), or those without concurrent TB or other AIDS-defining disease (“no disease”). Primary outcome was time to the first of virologic failure, HIV disease progression or death. Since the groups differed in characteristics, proportional hazard models were used to compare the hazard of the primary outcome among study groups, adjusting for age, sex, country, screening CD4 count, baseline viral load and ART regimen. Results: 31 of 102 participants (30%) in the “TB” group, 11 of 56 (20%) in the “other disease” group, and 287 of 1413 (20%) in the “no disease” group experienced a primary outcome event (p = 0.042). This difference reflected higher mortality in the TB group: 15 (15%), 0 (0%) and 41 (3%) participants died, respectively (p<0.001). The adjusted hazard ratio comparing the “TB” and “no disease” groups was 1.39 (95% confidence interval: 0.93–2.10; p = 0.11) for the primary outcome and 3.41 (1.72–6.75; p<0.001) for death. Conclusions: Active TB at ART initiation was associated with increased risk of mortality in HIV-1 infected patients.
ACCESSION #
93397558

 

Related Articles

  • The Effect of a Multidisciplinary Program on HAART Adherence. Frick, Pamela; Tapia, Kenneth; Grant, Philip; Novotny, Martina; Kerzee, Jane // AIDS Patient Care & STDs;Jul2006, Vol. 20 Issue 7, p511 

    Although emerging evidence suggests differing interventions may improve antiretroviral adherence, there has not been a formal evaluation to identify the impact of a clinic-based multidisciplinary program designed to provide education and identify and correct potential adherence barriers prior to...

  • Testing and Treatment After Non-Occupational Exposures To STDs and HIV. Hardy, Erica J. // Medicine & Health Rhode Island;Aug2012, Vol. 95 Issue 8, p258 

    The article discusses the new recommendations for the prophylaxis, testing, and treatment of adult patients after non-occupational exposures to sexually transmitted disease (STD) and human immunodeficiency virus (HIV). It states that enough time may not have elapsed for a STD test to be positive...

  • Linkage to Care and Treatment for TB and HIV among People Newly Diagnosed with TB or HIV-Associated TB at a Large, Inner City South African Hospital. De Lima, Yara Voss; Evans, Denise; Page-Shipp, Liesl; Barnard, Antonia; Sanne, Ian; Menezes, Colin N.; Van Rie, Annelies // PLoS ONE;Jan2013, Vol. 8 Issue 1, Special section p1 

    Objective: To assess the outcomes of linkage to TB and HIV care and identify risk factors for poor referral outcomes. Design: Cohort study of TB patients diagnosed at an urban hospital. Methods: Linkage to care was determined by review of clinic files, national death register, and telephone...

  • AIDS defining diseases in the UK: the impact of PCP prophylaxis and twelve years of change. Porter, Kholoud; Fairley, Christopher K.; Wall, Patrick G.; Evans, Barry G.; Goldberg, David J.; Weerasuriya, Melanie; Noone, Ahilya; Porter, K; Fairley, C K; Wall, P G; Evans, B G; Goldberg, D J; Weerasuriya, M; Noone, A // International Journal of STD & AIDS;Jul1996, Vol. 7 Issue 4, p252 

    We examined all reports of adult AIDS cases made to the 2 national surveillance centres in the UK for changes in AIDS defining conditions between January 1982 and September 1994. Differences and changes among persons diagnosed since January 1988 who had and had not been aware of their HIV...

  • My Quest to Improve Care. Clinton, Bill // Newsweek;5/15/2006, Vol. 147 Issue 20, p50 

    The article presents former United States President Bill Clinton's experiences fighting AIDS around the world. AIDS treatment has advanced tremendously since the disease was first identified, and can often prolong patients' lives greatly, but shortages and lack of funds can stop many people with...

  • My Quest to Improve Care. Clinton, Bill // Newsweek (Pacific Edition);6/5/2006 (Pacific Edition), Vol. 147 Issue 23, p42 

    The article presents former United States President Bill Clinton's experiences fighting AIDS around the world. AIDS treatment has advanced tremendously since the disease was first identified, and can often prolong patients' lives greatly, but shortages and lack of funds can stop many people with...

  • My Quest to Improve Care. Clinton, Bill // Newsweek (Atlantic Edition);6/5/2006 (Atlantic Edition), Vol. 147 Issue 23, p50 

    The article presents former United States President Bill Clinton's experiences fighting AIDS around the world. AIDS treatment has advanced tremendously since the disease was first identified, and can often prolong patients' lives greatly, but shortages and lack of funds can stop many people with...

  • Intensive-Phase Treatment Outcomes among Hospitalized Multidrug-Resistant Tuberculosis Patients: Results from a Nationwide Cohort in Nigeria. Oladimeji, Olanrewaju; Isaakidis, Petros; Obasanya, Olusegun J.; Eltayeb, Osman; Khogali, Mohammed; Van den Bergh, Rafael; Kumar, Ajay M. V.; Hinderaker, Sven Gudmund; Abdurrahman, Saddiq T.; Lawson, Lovett; Cuevas, Luis E. // PLoS ONE;Apr2014, Vol. 9 Issue 4, p1 

    Background: Nigeria is faced with a high burden of Human Immunodeficiency Virus (HIV) infection and multidrug-resistant tuberculosis (MDR-TB). Treatment outcomes among MDR-TB patients registered across the globe have been poor, partly due to high loss-to-follow-up. To address this challenge,...

  • Antiretroviral Use in Resource-Poor Settings: Modeling Its Impact.  // PLoS Medicine;Apr2006, Vol. 3 Issue 4, pe179 

    The article discusses Antiretroviral Therapy(ART) in the treatment of HIV/AIDS patients in resource-poor countries. The reduction in HIV mortality rate with ART access in affluent countries and the necessity of making rural Africa ART accessaible is discussed. A revelation of the study on...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics